Antipova, L. A., Loria, S. S., Semochkin, S. V., & Rumiantsev, A. G. (2022). Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®). ABV-press.
Chicago Style (17th ed.) CitationAntipova, L. A., S. S. Loria, S. V. Semochkin, and A. G. Rumiantsev. Long-term Treatment Outcome in Chronic Myeloid Leukemia Patients in Accelerated Phase Treated with Imatinib (glevec®). ABV-press, 2022.
MLA (9th ed.) CitationAntipova, L. A., et al. Long-term Treatment Outcome in Chronic Myeloid Leukemia Patients in Accelerated Phase Treated with Imatinib (glevec®). ABV-press, 2022.
Warning: These citations may not always be 100% accurate.